邹艳花,廖先珍,许可葵.2009—2018年湖南省肿瘤登记地区女性乳腺癌发病与死亡趋势分析[J].中国肿瘤,2022,31(5):341-347.
2009—2018年湖南省肿瘤登记地区女性乳腺癌发病与死亡趋势分析
Trend Analysis of Incidence and Mortality of Female Breast Cancer in Hunan Cancer Registration Areas from 2009 to 2018
投稿时间:2021-12-22  
DOI:10.11735/j.issn.1004-0242.2022.05.A004
中文关键词:  肿瘤登记  女性乳腺癌  发病率  死亡率  湖南
英文关键词:cancer registration  female breast cancer  incidence rate  mortality rate  Hunan
基金项目:
作者单位
邹艳花 湖南省肿瘤医院/中南大学湘雅医学院附属肿瘤医院/湖南省肿瘤防治研究办公室 
廖先珍 湖南省肿瘤医院/中南大学湘雅医学院附属肿瘤医院/湖南省肿瘤防治研究办公室 
许可葵 湖南省肿瘤医院/中南大学湘雅医学院附属肿瘤医院/湖南省肿瘤防治研究办公室 
摘要点击次数: 768
全文下载次数: 127
中文摘要:
      摘 要:[目的] 分析湖南省肿瘤登记地区2009—2018年女性乳腺癌的发病与死亡情况。 [方法] 收集2009—2018年湖南省32个肿瘤登记点上报的女性乳腺癌发病与死亡数据,按照地区计算湖南省女性乳腺癌的发病(死亡)率、中标发病(死亡)率,年龄别发病(死亡)率、0~74岁累积发病(死亡)率、 35~64 岁截缩发病(死亡)率和年度变化百分比(annual percentage change,APC)等指标。[结果] 2009—2018年湖南省肿瘤登记地区女性乳腺癌发病率为31.99/10万,0~74岁累积发病率为2.83%,35~64 岁截缩发病率56.63/10万,城市地区以上三项指标分别为42.72/10万、4.07%、71.36/10万,农村地区以上三项指标分别为26.38/10万、2.20%、48.81/10万。2009—2018年湖南省肿瘤登记地区女性乳腺癌死亡率为8.86/10万,0~74岁累积死亡率为1.00%,35~64 岁截缩死亡率13.49/10万,城市地区以上三项指标分别为11.73/10万、1.43%、16.86/10万,农村地区以上三项指标分别为7.36/10万、0.78%、11.69/10万。2009—2018年湖南省肿瘤登记地区女性乳腺癌中标发病率、0~74岁累积发病率、35~64 岁截缩发病率呈上升趋势,且均有统计学意义(P均<0.05),APC依次为4.1%、4.9%、4.3%。趋势变化均在2011年出现一个拐点,2009—2011年的趋势变化无统计学意义。2009—2018年湖南省肿瘤登记地区女性乳腺癌中标死亡率、0~74岁累积死亡率、35~64 岁截缩死亡率较为稳定,趋势变化无统计学意义。趋势均在2011年出现一个拐点,2011—2018年趋势变化均有统计学意义(P均<0.05)。2009—2018年湖南省肿瘤登记地区女性乳腺癌年龄别发病率峰值出现在50~54岁年龄组,年龄别死亡率呈持续增长趋势。[结论] 湖南省肿瘤登记地区女性乳腺癌发病率呈明显逐年增长趋势,死亡率也有上升趋势,应加强对女性乳腺癌的防治。
英文摘要:
      Abstract:[Purpose] To analyze the trend of incidence and mortality of female breast cancer in Hunan cancer registration areas from 2009 to 2018. [Methods] The new cases and deaths data of female breast cancer were collected from 32 cancer registries of Hunan Province. The crude incidence/mortality rate, age-standardized incidence/mortality rate by Chinese standard population(ASIRC/ASMRC), age-specific incidence/mortality rate, the cumulative incidence/mortality rate(0~74 years old), the truncated incidence/mortality rate(35~64 years old), annual percentage change(APC) were calculated by stratification of areas. [Results] The average crude incidence rate, the cumulative incidence rate(0~74 years old) and the truncated incidence rate(35~64 years old) of female breast cancer were 31.99/105, 2.83%, and 56.63/105, respectively in Hunan cancer registration areas from 2009 to 2018. These indicators were 42.72/105, 4.07% and 71.36/105 in urban areas; and 26.38/105, 2.20% and 48.81/105 in rural areas, respectively. The ASIRC, the cumulative incidence rate(0~74 years old) and the truncated incidence rate(35~64 years old) of female breast cancer from 2009 to 2018 showed a significantly increasing trend with the APC of 4.1%, 4.9% and 4.3%, respectively(all P<0.05). The trend of these indicators showed a turning point in 2011, and the trend changes from 2009 to 2011 were not statistically significant. The crude moryears old) of female breast cancer were 8.86/105, 1.00% and 13.49/105, respectively in Hunan cancer registration areas from 2009 to 2018. And the above three indicators were 11.73/105, 1.43% and 16.86/105 in urban areas, and 7.36/105, 0.78% and 11.69/105 in rural areas, respectively. The ASMRC, the cumulative mortality rate(0~74 years old) and the truncated mortality rate(35~64 years old) of female breast cancer were relatively stable(P>0.05). The trend showed a turning point in 2011, and from 2011 to 2018 the changes were statistically significant(all P<0.05). The age-specific incidence peaked at the age group of 50~54 years, and the age-specific mortality rate showed a continuous increase trend. [Conclusion] The incidence of female breast cancer in Hunan shows a significant increasing trend and the mortality rate is on the rise. The prevention and treatment of female breast cancer should be strengthened.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器